Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

Peer Review reports

Original Submission
27 Jul 2012	Submitted	Original manuscript
19 Aug 2012	Reviewed	Reviewer Report - Richard Pope
31 Aug 2012	Reviewed	Reviewer Report - saima chohan
10 Sep 2012	Author responded	Author comments - Nicola Dalbeth
Resubmission - Version 2
10 Sep 2012	Submitted	Manuscript version 2
Publishing
12 Sep 2012	Editorially accepted
16 Sep 2012	Article published	10.1186/1471-2474-13-174

Back to article page